Uphill Pharmaceuticals Private Limited - Company Profile

It is a business outsourcing private limited company based in Rohini, Delhi, India, established in 2006.
2006 Rohini, Delhi, India Converted to LLP
Last Updated:
Access Report
About Uphill Pharmaceuticals Private Limited

Uphill Pharmaceuticals Private Limited, a converted to llp private limited company, was established on 26 December 2006 in Rohini, Delhi, India. Engaging in business & it consulting within the professional, scientific and technical sector, it holds CIN: U24232DL2006PTC157020. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Past directors included Hari Kishore Kushwah, Khushboo Agarwal, Meenakshi Peshawari. Its latest AGM occurred on 27 December 2020, with the balance sheet filed on 31 March 2020. It is based at House No. 21, 1St Floor Blk-D, Parshant Vihar Landmark Near Central Market, Rohini, Delhi, 110085.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232DL2006PTC157020

  • Registration Number

    157020

  • Incorporation Date

    26 December 2006

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 1 Month
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth **** -2.29%
  • Profit Growth **** 92.92%
  • Ebitda **** 82.72%
  • Net Worth 22.78%
  • Total Assets **** 3.04%
Company report

Uphill Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Uphill Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Uphill Pharmaceuticals Private Limited?
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Mar 2014 Past
Pramod Abcsdd Additional Director 16 Aug 2012 Past
Pramod Abcsdd Additional Director 03 May 2021 Past
Pramod Abcsdd Director 03 May 2021 Past
Pramod Abcsdd Additional Director 16 Aug 2012 Past
Pramod Abcsdd Director 08 Mar 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uphill Pharmaceuticals.

Uphill Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.29% decrease. The company also saw a substantial improvement in profitability, with a 92.92% increase in profit. The company's net worth Soared by an impressive increase of 22.78%.

Uphill Pharmaceuticals revenue growth over time
Uphill Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -2.29%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.29%
*******
*******
*******
*******
Total Assets
*******
 3.04%
*******
*******
*******
*******
Profit or Loss
*******
 92.92%
*******
*******
*******
*******
Net Worth
*******
 22.78%
*******
*******
*******
*******
EBITDA
*******
 82.72%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uphill Pharmaceuticals?

In 2020, Uphill Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Uphill Pharmaceuticals?

Unlock and access historical data on people associated with Uphill Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uphill Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uphill Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uphill Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Uphill Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Dec 2020 as per latest MCA records. was completed.

  • Balance Sheet

    Uphill Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Delhi. was recorded as a recent event.

  • Company Incorporation

    The activity Uphill Pharmaceuticals Private Limited was registered on 26 Dec 2006 with Roc Delhi & aged 19 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uphill Pharmaceuticals Private Limited?

The CIN of Uphill Pharmaceuticals Private Limited is U24232DL2006PTC157020.

Where is Uphill Pharmaceuticals Private Limited headquartered?

Uphill Pharmaceuticals Private Limited is headquartered at House No. 21, 1St Floor Blk-D, Parshant Vihar Landmark Near Central Market, Rohini, Delhi, 110085.

When was Uphill Pharmaceuticals Private Limited incorporated?

Uphill Pharmaceuticals Private Limited was incorporated on 26 December 2006.

What is the primary industry of Uphill Pharmaceuticals Private Limited?

The primary industry of Uphill Pharmaceuticals Private Limited is Professional, Scientific And Technical.

Is Uphill Pharmaceuticals Private Limited a listed company?

Uphill Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Uphill Pharmaceuticals Private Limited?

The authorized capital of Uphill Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Uphill Pharmaceuticals Private Limited?

The compliance status of Uphill Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available